Botulinum A Toxin in Patients With Parkinson's Disease
Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The researchers investigated the effectiveness and safety of BoNT/A injected into the
detrusor muscle in patients with PD and MSA all of whom had detrusor muscle overactivity
unresponsive to conventional medical therapy.
Phase:
Phase 4
Details
Lead Sponsor:
University Of Perugia
Collaborator:
University of Roma La Sapienza
Treatments:
abobotulinumtoxinA Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA